Ambeed.cn

首页 / / / / UMI-77

UMI-77 {[allProObj[0].p_purity_real_show]}

货号:A102389

UMI-77是一种选择性 Mcl-1 SMI 抑制剂,能够与 Mcl-1 的 BH3 结合槽结合,Ki 值为 490 nM。

UMI-77 化学结构 CAS号:518303-20-3
UMI-77 化学结构
CAS号:518303-20-3
UMI-77 3D分子结构
CAS号:518303-20-3
UMI-77 化学结构 CAS号:518303-20-3
UMI-77 3D分子结构 CAS号:518303-20-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

UMI-77 纯度/质量文件 产品仅供科研

货号:A102389 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Bax Bcl-2 Bcl-B Bcl-w Bcl-xL Bfl-1 Mcl-1 其他靶点 纯度
BTSA1 99%+
HA14-1 +

Bcl-2, IC50: 9 μM

98%
Venetoclax ++++

Bcl-2, Ki: <0.01 nM

99%
Navitoclax 99%+
Obatoclax Mesylate +++

Bcl-2, Ki: 0.22 μM

99%
ABT-737 +++

Bcl-2, EC50: 30.3 nM

+

Bcl-B, EC50: 1.82 μM

+++

Bcl-w, EC50: 197.8 nM

+++

Bcl-xL, EC50: 78.7 nM

99%+
Gambogic Acid +

Bcl-2, IC50: 1.21 μM

Bfl-1, IC50: 1.06 μM

++

Bcl-B, IC50: 0.66 μM

++++

Bcl-w, IC50: 0.02 μM

+

Bcl-xL, IC50: 1.47 μM

+

Bfl-1, IC50: 1.06 μM

++

Mcl-1, IC50: 0.79 μM

Caspase 99% HPLC
BH3I-1 +

BH3-Bcl-xL interaction, Ki: 2.4 μM

99%
A-1331852 ++++

Bcl-xL, Ki: <0.01 nM

99%+
A-1210477 ++++

MCL-1, IC50: 26.2 nM

99%+
Maritoclax 97%
TW-37 +++

Bcl-2, Ki: 0.29 μM

+

Bcl-xL, Ki: 1.11 μM

+++

Mcl-1, Ki: 0.26 μM

98%
UMI-77 ++

Mcl-1, Ki: 490 nM

97%
(R)-(-)-Gossypol acetic acid ++

Bcl-2, Ki: 0.32 μM

++

Bcl-xL, Ki: 0.48 μM

+++

Mcl-1, Ki: 0.18 μM

99%
Sabutoclax ++

Bcl-2, IC50: 0.32 μM

Bfl-1, IC50: 0.62 μM

++

Bcl-xL, IC50: 0.31 μM

++

Bfl-1, IC50: 0.62 μM

+++

Mcl-1, IC50: 0.20 μM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

UMI-77 生物活性

靶点
  • Mcl-1

    Mcl-1, Ki:490 nM

描述 Mcl-1 (Myeloid cell leukemia-1) is an anti-apoptotic protein, which is a member of the Bcl-2 family. Mcl-1 is involved in the regulation of apoptosis versus cell survival, and in the maintenance of cell viability but not of proliferation. Mcl-1 mediates its effects by interactions with a number of other regulators of apoptosis[3]. UMI-77 is a Mcl-1 inhibitor. In FP-based binding assays, UMI-77 potently and selectively displaced fluorescent labeled BID-BH3 peptide from Mcl-1 protein. UMI-77 bound to the BH3 binding pocket of Mcl-1 and the Ki value was 0.49 μM[4]. In a pull-down assay, starting from the concentration of 10 μM , UMI-77 dose-dependently inhibited the interactions between BL-Noxa and cellular Mcl-1 in 2LMP cell lysates. In a SPR-based binding assay, it was reported that UMI-77 dose-dependently inhibited the binding of Mcl-1 to Bax with IC50 value of 1.43 μM. UMI-77 inhibited the growth of BxPC-2 and Panc-1 cells with IC50 values of 3.4 μM and 4.4 μM, respectively[4]. UMI-77 incubated at the concentrations of 3 μM or 10 μM for 48h induced apoptosis in esophageal squamous cell carcinoma KYSE150 and KYSE510 cells, as evidenced by cleavage of caspase-3 and PARP[5]. In BxPC-3 xenograft model established in SCID mice, UMI-77 administrated i.v. at the dose of 60 mg/kg for a total of 10 doses significantly inhibited tumor growth[4].
作用机制 UMI-77 is a Mcl-1 inhibitor. Docking and spectroscopy studies revealed that UMI-77 bound to the BH3 binding pocket of Mcl-1[4].

UMI-77 细胞实验

Cell Line
Concentration Treated Time Description References
HEK293T 5 µM 12 hours UMI-77 induces mitophagy without causing mitochondrial damage or apoptosis. Nat Commun. 2020 Nov 12;11(1):5731.
ME4405 cells 4 µM 24 hours To evaluate the apoptosis-inducing effect of UMI-77 on ME4405 cells, results showed that OVAAL overexpression conferred resistance to UMI-77-induced apoptosis. Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11661-E11670.
HCT116 cells 4 µM 24 hours To evaluate the apoptosis-inducing effect of UMI-77 on HCT116 cells, results showed that OVAAL knockdown enhanced UMI-77-induced apoptosis. Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11661-E11670.
BxPC-3 cells 3.4 µM (IC50) 4 days UMI-77 inhibits BxPC-3 cell growth with IC50 of 3.4 μM Mol Cancer Ther. 2014 Mar;13(3):565-75.
Panc-1 cells 4.4 µM (IC50) 4 days UMI-77 inhibits Panc-1 cell growth with IC50 of 4.4 μM Mol Cancer Ther. 2014 Mar;13(3):565-75.
MiaPaCa-2 cells 12.5 µM (IC50) 4 days UMI-77 inhibits MiaPaCa-2 cell growth with IC50 of 12.5 μM Mol Cancer Ther. 2014 Mar;13(3):565-75.
AsPC-1 cells 16.1 µM (IC50) 4 days UMI-77 inhibits AsPC-1 cell growth with IC50 of 16.1 μM Mol Cancer Ther. 2014 Mar;13(3):565-75.
Capan-2 cells 5.5 µM (IC50) 4 days UMI-77 inhibits Capan-2 cell growth with IC50 of 5.5 μM Mol Cancer Ther. 2014 Mar;13(3):565-75.
MN9D cells 10 µM 4 hours UMI-77 significantly increased the level of cleaved caspase-3 in MN9D cells and induced cell death. Cell Death Discov. 2018 Nov 21;4:107.
N2A cells 10 µM 4 hours UMI-77 had no significant effect on the level of cleaved caspase-3 in N2A cells. Cell Death Discov. 2018 Nov 21;4:107.
AGS cells 8 µM (IC50) 48 hours and 72 hours To evaluate the sensitivity of AGS cells to UMI-77, results showed that AGS cells were more sensitive to UMI-77. Front Immunol. 2024 Jun 27;15:1428529.
MKN45 cells 125 µM (IC50) 48 hours and 72 hours To evaluate the sensitivity of MKN45 cells to UMI-77, results showed that MKN45 cells were less sensitive to UMI-77. Front Immunol. 2024 Jun 27;15:1428529.
NB4 cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours and resulted in extensive PARP cleavage in NB4 cells after 12 hours, indicating indirect inhibition of MCL1 through NOXA induction. Cell Death Dis. 2019 Feb 22;10(3):185.
Jurkat cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. Cell Death Dis. 2019 Feb 22;10(3):185.
U937 cells 15–30 µM 6 hours UMI-77 induced NOXA protein expression within 6 hours, indicating indirect inhibition of MCL1 through NOXA induction. Cell Death Dis. 2019 Feb 22;10(3):185.
HeLa 5 µM 8 hours UMI-77 promotes degradation of mitochondrial proteins without affecting endoplasmic reticulum or cytosolic markers. Nat Commun. 2020 Nov 12;11(1):5731.
HGPS-MSCs 1 µM UMI-77 significantly improved the mitochondrial function of HGPS-MSCs, as evidenced by decreased ROS levels, reduced mitochondrial depolarization, and increased basal and maximal respiration levels. Aging Cell. 2024 Jun;23(6):e14143.

UMI-77 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Pitx3GFP/+ mice Pitx3GFP/+ mice Brain slice culture 10 µM Overnight treatment UMI-77 treatment increased the number of cleaved caspase-3 positive cells in brain slices of Pitx3GFP/+ mice, indicating that Mcl1 plays a crucial role in the survival of dopaminergic neurons. Cell Death Discov. 2018 Nov 21;4:107.
APP/PS1 (C57BL/6) mice APP/PS1 mouse model Intraperitoneal injection 10 mg/kg Every other day for 4 months UMI-77 significantly improved learning and memory in APP/PS1 mice, reduced Aβ plaques and neuroinflammation, and restored mitochondrial morphology. Nat Commun. 2020 Nov 12;11(1):5731.
Mice LmnaG608G/G608G mice Intragastric administration 20 mg/kg Every other day for 5 months UMI-77 restored mitochondrial morphology and function in HGPS mice, reduced aging-related tissue changes (such as loss of collagen fibers in the skin and fibrosis in the aorta, heart, muscles, and spleen), and significantly improved the overall health of the mice, including increased hair and weight, enhanced skeletal muscle strength, spatial working memory, and mobility, and extended the lifespan of the mice. Aging Cell. 2024 Jun;23(6):e14143.
Mice C57/BL6J mice Intraperitoneal injection 5 mg/kg Once daily for 14 days or 49 days UMI-77 promotes mitophagy in the hippocampus of adult mice, enhances neurogenesis, and prolongs the duration of spatial memory. CNS Neurosci Ther. 2024 Jun;30(6):e14800
SCID mice BxPC-3 xenograft model Intravenous injection 60 mg/kg 5 days per week for 2 weeks UMI-77 significantly inhibited tumor growth in the BxPC-3 xenograft model Mol Cancer Ther. 2014 Mar;13(3):565-75.
BALB/c mice Sepsis-induced acute lung injury model Intraperitoneal injection 7.0 mg/kg Once daily for five days UMI-77 significantly ameliorated histopathological changes in the lungs of mice with sepsis-induced ALI and exerted therapeutic effects by modulating key genes and metabolites. J Inflamm Res. 2024 Dec 18;17:11197-11209

UMI-77 动物研究

Dose Mice: 60 mg/kg[2] (i.v.)
Administration i.v.

UMI-77 参考文献

[1]Liu JW, Zhu ZC, ET AL. UMI-77 primes glioma cells for TRAIL-induced apoptosis by unsequestering Bim and Bak from Mcl-1. Mol Cell Biochem. 2017 Aug;432(1-2):55-65.

[2]Abulwerdi F, Liao C, et al. A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther. 2014 Mar;13(3):565-75.

[3]Bingle CD, Craig RW, Swales BM, Singleton V, Zhou P, Whyte MK. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem. 2000 Jul 21;275(29):22136-46.

[4]Aboukameel A, Mady AS, Gulappa T, Cierpicki T, Owens S, Zhang T, Sun D, Stuckey JA, Mohammad RM, Nikolovska-Coleska Z. A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther. 2014 Mar;13(3):565-75.

[5]Yu X, Li W, Xia Z, Xie L, Ma X, Liang Q, Liu L, Wang J, Zhou X, Yang Y, Liu H. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. BMC Cancer. 2017 Jun 28;17(1):449.

UMI-77 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.68mL

2.14mL

1.07mL

21.35mL

4.27mL

2.14mL

UMI-77 技术信息

CAS号518303-20-3
分子式C18H14BrNO5S2
分子量 468.34
SMILES Code O=C(O)CSC1=CC(NS(=O)(C2=CC=C(Br)C=C2)=O)=C3C=CC=CC3=C1O
MDL No. MFCD03471890
别名
运输蓝冰
InChI Key WUGANDSUVKXMEC-UHFFFAOYSA-N
Pubchem ID 992586
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 30 mg/mL(64.06 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。